Molecular Psychiatry
Mendelian Randomization Study
Cell-Specific Gene Expression Analysis Identifies Schizophrenia Risk Drivers
Researchers mapped 466 causal genes across eight brain cell types, pinpointing MAU2 and PPP1R13B as high-priority therapeutic targets.
Nature Aging
Mendelian Randomization Study
Beta-1 Blockers May Reduce Vascular Dementia Risk in Genetic Analysis
A Mendelian randomization study suggests beta-1 adrenergic antagonism protects white matter, while ACE inhibition may increase risk.